Evan Seigerman
Stock Analyst at BMO Capital
(4.35)
# 1,242
Out of 4,421 analysts
976
Total ratings
51.2%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,300 | $1,112.00 | +16.91% | 116 | Jun 14, 2026 | |
| INCY Incyte | Maintained: Sell | $75 | $98.99 | -24.23% | 50 | Jun 14, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $45 | $43.52 | +3.40% | 48 | Jun 7, 2026 | |
| PFE Pfizer | Maintained: Buy | $34 | $25.92 | +31.17% | 51 | Jun 6, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | $145 | $45.00 | +222.22% | 20 | Jun 5, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $100 | $70.21 | +42.43% | 30 | Jun 2, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $10 | $6.19 | +61.55% | 7 | Jun 1, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $730 | $607.93 | +20.08% | 76 | May 21, 2026 | |
| BIIB Biogen | Maintained: Hold | $196 | $198.67 | -1.34% | 60 | May 14, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $55.28 | +8.54% | 66 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $34 | $21.60 | +57.41% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $144 | $159.00 | -9.43% | 45 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $92.22 | +38.80% | 13 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.44 | +28.68% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $24 | $15.53 | +54.54% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $341.66 | +17.08% | 66 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $115.44 | +16.94% | 45 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $458.99 | +30.72% | 67 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 | $221.23 | +16.62% | 25 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $11 → $1 | $10.00 | -90.00% | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $174 | $125.45 | +38.70% | 76 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $46.95 | +49.09% | 9 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $72 → $112 | $111.44 | +0.50% | 4 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $30.79 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.67 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.92 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €114.57 → €130.19 | $132.90 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.99 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.33 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $5.69 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €135.00 → €129.00 | $24.76 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $0.9701 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $3.97 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $169 → $220 | $28.37 | n/a | 2 | Feb 24, 2020 |
Eli Lilly and Company
Jun 14, 2026
Maintained: Buy
Price Target: $1,300
Current: $1,112.00
Upside: +16.91%
Incyte
Jun 14, 2026
Maintained: Sell
Price Target: $75
Current: $98.99
Upside: -24.23%
Novo Nordisk
Jun 7, 2026
Reiterated: Hold
Price Target: $45
Current: $43.52
Upside: +3.40%
Pfizer
Jun 6, 2026
Maintained: Buy
Price Target: $34
Current: $25.92
Upside: +31.17%
Structure Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $145
Current: $45.00
Upside: +222.22%
Disc Medicine
Jun 2, 2026
Maintained: Buy
Price Target: $100
Current: $70.21
Upside: +42.43%
Taysha Gene Therapies
Jun 1, 2026
Reiterated: Buy
Price Target: $10
Current: $6.19
Upside: +61.55%
Regeneron Pharmaceuticals
May 21, 2026
Maintained: Buy
Price Target: $730
Current: $607.93
Upside: +20.08%
Biogen
May 14, 2026
Maintained: Hold
Price Target: $196
Current: $198.67
Upside: -1.34%
Bristol-Myers Squibb Company
May 13, 2026
Maintained: Hold
Price Target: $60
Current: $55.28
Upside: +8.54%
May 11, 2026
Maintained: Buy
Price Target: $26 → $34
Current: $21.60
Upside: +57.41%
May 11, 2026
Maintained: Hold
Price Target: $144
Current: $159.00
Upside: -9.43%
May 11, 2026
Maintained: Buy
Price Target: $128
Current: $92.22
Upside: +38.80%
May 11, 2026
Maintained: Buy
Price Target: $7
Current: $5.44
Upside: +28.68%
May 5, 2026
Maintained: Buy
Price Target: $32 → $24
Current: $15.53
Upside: +54.54%
May 4, 2026
Maintained: Buy
Price Target: $400
Current: $341.66
Upside: +17.08%
May 4, 2026
Maintained: Buy
Price Target: $135
Current: $115.44
Upside: +16.94%
May 4, 2026
Maintained: Buy
Price Target: $600
Current: $458.99
Upside: +30.72%
May 4, 2026
Maintained: Buy
Price Target: $258
Current: $221.23
Upside: +16.62%
Apr 13, 2026
Downgraded: Sell
Price Target: $11 → $1
Current: $10.00
Upside: -90.00%
Apr 7, 2026
Maintained: Buy
Price Target: $160 → $174
Current: $125.45
Upside: +38.70%
Mar 18, 2026
Reiterated: Buy
Price Target: $70
Current: $46.95
Upside: +49.09%
Oct 13, 2025
Maintained: Buy
Price Target: $72 → $112
Current: $111.44
Upside: +0.50%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $30.79
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $7.67
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Oct 23, 2024
Maintained: Buy
Price Target: €114.57 → €130.19
Current: $132.90
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $7.99
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $5.33
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $30 → $27
Current: $5.69
Upside: n/a
Oct 16, 2020
Maintained: Hold
Price Target: €135.00 → €129.00
Current: $24.76
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $0.9701
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $3.97
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $169 → $220
Current: $28.37
Upside: n/a